• Return to Headlines

Alder Biopharmac Up 90.2% Since SmarTrend Uptrend Call (ALDR)

By Amy Schwartz

SmarTrend identified an Uptrend for Alder Biopharmac (NASDAQ:ALDR) on September 13th, 2019 at $9.93. In approximately 8 months, Alder Biopharmac has returned 90.23% as of today's recent price of $18.89.

Over the past year, Alder Biopharmac has traded in a range of $8.39 to $18.99 and is now at $18.89, 125% above that low. Over the last five market days, the 200-day moving average (MA) has remained constant while the 50-day MA has remained constant.

Alder Biopharmaceuticals, Inc. provides pharmaceutical products and services. The Company identifies, develops, and manufactures antibody therapeutics to alleviate human suffering in cancer, pain, cardiovascular, and autoimmune and inflammatory disease areas. Alder Biopharmaceuticals operates in the United States.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Alder Biopharmac shares.

Log in and add Alder Biopharmac (ALDR) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights alder biopharmac

Ticker(s): ALDR